Literature DB >> 19857605

The crosstalk between thyroid hormones and the Renin-Angiotensin System.

Maria Luiza M Barreto-Chaves1, Maria Alícia Carrillo-Sepúlveda, Marcela S Carneiro-Ramos, Dayane A Gomes, Gabriela P Diniz.   

Abstract

Thyroid hormones (THs) exert multiple effects on the heart and vascular system. As a consequence, altered cardiovascular function observed in the thyroid diseases corresponds to one of the most important and clinically relevant aspects found in both hyperthyroidism and hypothyroidism. Besides THs' direct effects on the heart and vascular system, in the last three decades several studies have implicated the Renin-Angiotensin System (RAS) in some of the cardiovascular effects of THs, with this interaction suggesting that RAS may be an important mediator of THs actions. In the present review, we discuss the alterations in the circulating RAS, as well as modifications in cardiac and vascular RAS which are involved in the cardiovascular alterations found during the modulation of TH levels. In addition, considering the important role that both systems present during fetal and neonatal periods, we also review the interaction between THs and the RAS in the development of cardiovascular system. A greater understanding of the role of the RAS in hyperthyroidism and hypothyroidism, during early or adult life will presumably facilitate the evolution of newer, targeted therapies. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19857605     DOI: 10.1016/j.vph.2009.10.009

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  11 in total

1.  Modification of gene expression profiling related to renin-angiotensin system in an ischemia/reperfusion rat model after T3 infusion.

Authors:  Laura Sabatino; Silvana Balzan; Claudia Kusmic; Giorgio Iervasi
Journal:  Mol Cell Biochem       Date:  2018-05-08       Impact factor: 3.396

2.  AT1 receptor blockage impairs NF-κB activation mediated by thyroid hormone in cardiomyocytes.

Authors:  Ana Paula Cremasco Takano; Nathalia Senger; Carolina Demarchi Munhoz; Maria Luiza Morais Barreto-Chaves
Journal:  Pflugers Arch       Date:  2017-11-25       Impact factor: 3.657

3.  Ischemia and No Obstructive Coronary Artery Disease and Pulmonary Hypertension in a 16-Year-Old Girl with Unquenched Hyperthyroidism of Graves' Disease.

Authors:  Meng-Luen Lee; Ming-Che Chang; Yu-Mei Wang
Journal:  Acta Cardiol Sin       Date:  2021-07       Impact factor: 2.672

4.  Concurrence of Persistent Pulmonary Hypertension of the Newborn, Myocardial Ischemia, Supraventricular Tachycardia, and Congestive Heart Failure as a Harbinger of Neonatal Graves' Disease.

Authors:  Meng-Luen Lee; Yu-Mei Wang; Ming-Che Chang
Journal:  Acta Cardiol Sin       Date:  2020-05       Impact factor: 2.672

5.  Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy.

Authors:  Gabriela P Diniz; Nathalia Senger; Marcela S Carneiro-Ramos; Robson A S Santos; Maria Luiza M Barreto-Chaves
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-12-28

6.  Decreased number of circulating endothelial progenitor cells in patients with Graves' hyperthyroidism.

Authors:  C De Ciuceis; A Pilu; C Cappelli; E Porteri; F Zani; A Santoro; E Gandossi; G E M Boari; N Rizzardi; M Castellano; D Rizzoni; E Agabiti Rosei
Journal:  J Endocrinol Invest       Date:  2010-06-28       Impact factor: 4.256

7.  Cardioprotective effect of thyroid hormone is mediated by AT2 receptor and involves nitric oxide production via Akt activation in mice.

Authors:  Ivson Bezerra da Silva; Dayane Aparecida Gomes; Natalia Alenina; Michael Bader; Robson Augusto Dos Santos; Maria Luiza M Barreto-Chaves
Journal:  Heart Vessels       Date:  2017-12-07       Impact factor: 2.037

8.  Ascending haemorrhagic myelomalacia associated with systemic hypertension in a hyperthyroid cat.

Authors:  Alexandra Ferreira; Jacques Sottiaux; Maria Teresa Mandara; Luca Motta
Journal:  JFMS Open Rep       Date:  2015-06-16

9.  Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves' disease.

Authors:  Yuki Mizuguchi; Satoshi Morimoto; Shihori Kimura; Noriyoshi Takano; Kaoru Yamashita; Yasufumi Seki; Kanako Bokuda; Midori Yatabe; Junichi Yatabe; Daisuke Watanabe; Takashi Ando; Atsuhiro Ichihara
Journal:  PLoS One       Date:  2018-04-05       Impact factor: 3.240

10.  Emerging role of angiotensin type 2 receptor (AT2R)/Akt/NO pathway in vascular smooth muscle cell in the hyperthyroidism.

Authors:  Maria Alícia Carrillo-Sepúlveda; Graziela S Ceravolo; Cristina R Furstenau; Priscilla de Souza Monteiro; Zuleica Bruno-Fortes; Maria Helena Carvalho; Francisco R Laurindo; Rita C Tostes; R Clinton Webb; Maria Luiza M Barreto-Chaves
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.